BIOMAT Database Logo BIOMAT Database Logo

How to overcome antiviral-resistant hepatitis B virus? 2010

Byung-Cheol Song
Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea. drsong@jejunu.ac.kr

The goal of antiviral therapy in patients with chronic hepatitis B is long-lasting suppression of hepatitis B virus (HBV) DNA, normalization of serum alanine aminotransferase and prevention of progression of chronic liver disease to liver cirrhosis, hepatocellular carcinoma and death. Even though substantial advances have been made in the treatment of chronic hepatitis B in the past decade with the use of oral nucleoside/nucleotide analogs, emergence of antiviral resistance is the most important factor in treatment failure for chronic hepatitis B. Herein, we will discuss how to prevent antiviral resistance.

UI MeSH Term Description Entries
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral
D019694 Hepatitis B, Chronic INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Chronic Hepatitis B,Chronic Hepatitis B Virus Infection,Hepatitis B Virus Infection, Chronic
D020125 Mutation, Missense A mutation in which a codon is mutated to one directing the incorporation of a different amino acid. This substitution may result in an inactive or unstable product. (From A Dictionary of Genetics, King & Stansfield, 5th ed) Missense Mutation,Missense Mutations,Mutations, Missense
D024882 Drug Resistance, Viral The ability of viruses to resist or to become tolerant to chemotherapeutic agents or antiviral agents. This resistance is acquired through gene mutation. Antiviral Drug Resistance,Antiviral Drug Resistances,Drug Resistances, Viral

Related Publications

Byung-Cheol Song
[Management of antiviral-resistant chronic hepatitis B virus infection].
June 2008, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi,
Byung-Cheol Song
Sensitivity of L-(-)2,3-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues.
June 1999, Biochemical pharmacology,
Byung-Cheol Song
Hepatitis B virus serology to predict antiviral response in chronic hepatitis B.
January 2011, Digestion,
Byung-Cheol Song
Innate antiviral immune responses to hepatitis B virus.
July 2010, Viruses,
Byung-Cheol Song
Hepatitis B virus infection: resistance to antiviral agents.
June 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Byung-Cheol Song
Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?
November 2007, Journal of viral hepatitis,
Byung-Cheol Song
Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model.
May 2009, Hepatology (Baltimore, Md.),
Byung-Cheol Song
[Antiviral therapy of chronic hepatitis B patients resistant to lamivudine].
December 2005, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,
Byung-Cheol Song
Hepatitis B virus genotypes and response to antiviral therapy.
January 2006, Clinical laboratory,
Byung-Cheol Song
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region.
March 2001, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!